Mifepristone and misoprostol in California pharmacies after modifications to the Risk Evaluation and Mitigation Strategy Program
Authors:
- 26 May 2024
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 137, 110506
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Medication abortion with misoprostol-only: A sample protocolContraception, 2023
- Medication abortion: Advocating for mifepristone dispensing by pharmacistsContraception, 2021
- An introduction to risk evaluation and mitigation strategiesContraception, 2021